Navigation Links
North & South American researchers find architectural abnormalities in T. cruzi ribosome

the genetic translational machinery of the Chagas parasite. Unlike in other organisms, an identical string of 39 nucleotides is spliced onto the lead end of every mRNA molecule, no matter which protein is to be made. And, as Levin and his colleagues discovered years ago, the heart damage associated with Chagas disease is triggered by antibodies formed by an infected individual's immune system in response to a unique ribosomal protein from the parasite.

Chagas disease exists only on the American continent, according to the World Health Organization. It is caused by a parasite called Trypanosoma cruzi, which is transmitted to humans by a blood-sucking bug usually found in poor areas with substandard housing. An estimated 16 to 18 million people in Latin America are infected, and another 100 million are at risk. Some cases have spread through blood transfusion. Screening blood for the disease is mandatory in many Latin American countries, where more blood is infected by the parasite than by HIV and hepatitis B and C, but not in the United States, where the disease is rare.

For a few people, symptoms may begin within a few days or weeks. Most people may not know they have the disease for a decade or more, during which time 20 to 30 percent will develop potentially deadly cardiac problems. According to Levin, there is an urgent need for a more reliable treatment for this chronic phase of the infection.

In addition to the public health implications, Frank sees the parasite as a primitive link to modern eukaryotes and its ribosome as a source of potential insights into the evolution of more complex organisms.

"Ribosomes perform the translation of genetic information into protein in all organisms," Frank said. "The principle is always the same in plants, bacteria, and humans. It's a fundamental property of life on Earth."

Another HHMI investigator, Thomas A. Steitz of Yale University, produced the first atomic-resolution images of the
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3 4

Related biology news :

1. Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
2. No relief for Pacific Northwest drought
3. Survey finds silver contamination in North Pacific waters
4. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
5. Habitat use by North Pacific right whales, Eubalaena japonica, in the Bering Sea and Gulf of Alaska
6. Red delicious, Northern Spy apples have most antioxidants, chemists find
7. FSU scientist warns North Atlantic right whale facing extinction
8. Proposal would allow wild animals to roam North America
9. Drug resistant avian influenza viruses more common in Southeast Asia than North America
10. Skin disease common among Hispanic farmworkers in North Carolina, research shows
11. First wolverine radio-collared in Pacific Northwest
Post Your Comments:
Other Biology Technology:The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies 2The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies 3The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies 4The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies 5The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 8The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System 2The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System 3The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System 4The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System 5